From: Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
Covariates | Univariate Cox model | Multivariate Cox model | ||
---|---|---|---|---|
Crude HR (90% CI) | p value | Adjusted HR (95% CI) | p value | |
Sex (Male) | 1.63 (1.42, 1.86) | < 0.001 | 1.32 (1.07, 1.64) | 0.01 |
Age at diagnosis (+ 5 years) | 1.08 (1.05, 1.12) | < 0.001 |  |  |
Smoking (Yes) | 1.31 (1.15, 1.49) | < 0.001 |  |  |
BMI (+ 1) | 1.00 (0.99, 1.01) | 0.21 |  |  |
Chemotherapy (Yes) | 0.60 (0.53, 0.68) | < 0.001 | 0.55 (0.47, 0.64) | < 0.001 |
Comorbidities (Yes) | 0.95 (0.85, 1.09) | 0.57 | Â | Â |
Histological type | ||||
 Squamous cell carcinoma | 1.36 (1.19, 1.55) | < 0.001 |  |  |
 Large cell carcinoma | 0.82 (0.39, 1.71) | 0.65 |  |  |
 Multiple types | 1.76 (1.28, 2.41) | 0.003 | 1.77 (1.20, 2.61) | 0.017 |
Stage (Advanced stage) | 4.95 (3.40, 7.21) | < 0.001 | 4.78 (3.18, 7.18) | < 0.001 |
Baseline serum ALB (> = 35 U/L) | 0.40 (0.33, 0.48) | < 0.001 | 0.53 (0.42, 0.68) | < 0.001 |
Baseline serum NLR (+ 5) | 1.34 (1.28, 1.40) | < 0.001 | 1.25 (1.17, 1.34) | < 0.001 |
Baseline serum ChE (> = 7700 U/L) | 0.61 (0.53, 0.69) | < 0.001 | 0.77 (0.67, 0.93) | 0.006 |